Free Trial

Accelerant (ARX) Financials

Accelerant logo
$19.88 +0.03 (+0.13%)
As of 12:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Accelerant

Annual Income Statements for Accelerant

This table shows Accelerant's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-49 27 -1,425
Consolidated Net Income / (Loss)
-64 23 -1,345
Net Income / (Loss) Continuing Operations
-64 23 -1,345
Total Pre-Tax Income
-44 32 -1,322
Total Operating Income
17 78 -1,187
Total Gross Profit
344 603 -467
Total Revenue
344 603 913
Operating Revenue
344 603 913
Total Cost of Revenue
0.00 0.00 1,380
Operating Cost of Revenue
0.00 0.00 1,380
Total Operating Expenses
327 525 720
Selling, General & Admin Expense
183 249 400
Depreciation Expense
15 27 35
Amortization Expense
50 81 80
Other Operating Expenses / (Income)
80 167 204
Total Other Income / (Expense), net
-61 -46 -135
Interest Expense
11 12 11
Other Income / (Expense), net
-50 -34 -124
Income Tax Expense
20 9.10 23
Preferred Stock Dividends Declared
0.00 0.00 71
Net Income / (Loss) Attributable to Noncontrolling Interest
-15 -4.30 8.90
Basic Earnings per Share
($0.29) $0.16 ($7.49)
Weighted Average Basic Shares Outstanding
165.60M 165.98M 190.26M
Diluted Earnings per Share
($0.29) $0.14 ($7.49)
Weighted Average Diluted Shares Outstanding
165.60M 199.66M 190.26M
Weighted Average Basic & Diluted Shares Outstanding
- - 222.16M

Quarterly Income Statements for Accelerant

This table shows Accelerant's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-9.00 8.10 6.50 8.80 -1,440 -5.20 79 -12
Consolidated Net Income / (Loss)
-9.20 9.40 7.80 13 -1,367 -4.10 80 -9.20
Net Income / (Loss) Continuing Operations
-9.20 9.40 7.80 13 -1,367 -4.10 80 -9.20
Total Pre-Tax Income
-4.30 1.30 16 22 -1,358 2.00 87 -1.60
Total Operating Income
7.50 18 33 52 -1,312 24 111 26
Total Gross Profit
130 154 178 219 -1,112 273 357 279
Total Revenue
130 154 178 219 267 273 357 279
Operating Revenue
130 154 178 219 267 273 357 279
Total Cost of Revenue
0.00 0.00 0.00 0.00 1,380 0.00 0.00 0.00
Operating Cost of Revenue
- 0.00 - - 1,380 - - 0.00
Total Operating Expenses
123 136 145 167 199 249 246 252
Selling, General & Admin Expense
58 67 75 89 116 124 130 140
Depreciation Expense
5.50 5.80 7.40 8.30 10 10 10 11
Amortization Expense
16 23 17 18 23 34 35 31
Other Operating Expenses / (Income)
43 40 45 51 51 82 72 71
Total Other Income / (Expense), net
-12 -17 -18 -30 -46 -22 -23 -28
Interest Expense
3.00 3.10 2.60 2.50 2.60 2.50 2.40 2.40
Other Income / (Expense), net
-8.80 -13 -15 -27 -43 -20 -21 -25
Income Tax Expense
4.90 -8.10 7.70 9.20 9.50 6.10 7.40 7.60
Preferred Stock Dividends Declared
- 0.00 - - 71 - - 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.20 1.30 1.30 4.30 1.80 1.10 1.30 3.10
Basic Earnings per Share
($0.05) $0.05 $0.04 $0.05 ($6.99) ($0.02) $0.36 ($0.06)
Weighted Average Basic Shares Outstanding
165.95M 166.19M 166.19M 166.19M 206.06M 221.98M 218.41M 217.17M
Diluted Earnings per Share
($0.05) $0.04 $0.03 $0.04 ($6.99) ($0.02) $0.36 ($0.06)
Weighted Average Diluted Shares Outstanding
165.95M 199.71M 205.27M 205.95M 206.06M 221.98M 219.69M 217.17M
Weighted Average Basic & Diluted Shares Outstanding
- - - 219.99M 221.82M 218.20M 217.19M 217.37M

Annual Cash Flow Statements for Accelerant

This table details how cash moves in and out of Accelerant's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
288 516 477
Net Cash From Operating Activities
290 786 445
Net Cash From Continuing Operating Activities
290 786 445
Net Income / (Loss) Continuing Operations
-64 23 -1,345
Consolidated Net Income / (Loss)
-64 23 -1,345
Depreciation Expense
15 27 35
Amortization Expense
-0.50 -5.70 -7.60
Non-Cash Adjustments To Reconcile Net Income
-43 65 929
Changes in Operating Assets and Liabilities, net
383 677 834
Net Cash From Investing Activities
-13 -380 -174
Net Cash From Continuing Investing Activities
-13 -380 -174
Purchase of Property, Plant & Equipment
-33 -34 -41
Acquisitions
1.90 -4.80 -12
Purchase of Investments
-121 -501 -509
Divestitures
0.00 0.00 1.10
Sale and/or Maturity of Investments
140 162 388
Other Investing Activities, net
-1.30 -1.70 -0.50
Net Cash From Financing Activities
10 110 206
Net Cash From Continuing Financing Activities
10 110 206
Repayment of Debt
18 -0.70 -5.80
Repurchase of Preferred Equity
0.00 0.00 -175
Payment of Dividends
-8.40 -3.50 -10
Issuance of Debt
0.00 0.00 5.00
Issuance of Preferred Equity
0.70 115 0.00
Issuance of Common Equity
0.00 0.00 392
Cash Interest Paid
10 11 10
Cash Income Taxes Paid
20 46 59

Quarterly Cash Flow Statements for Accelerant

This table details how cash moves in and out of Accelerant's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
208 207 -0.20 128 227 123 -252 123 449
Net Cash From Operating Activities
276 242 92 218 74 62 -21 -69 321
Net Cash From Continuing Operating Activities
276 242 92 218 74 62 -21 -69 321
Net Income / (Loss) Continuing Operations
9.40 21 7.80 13 -1,367 0.90 -4.10 80 -9.20
Consolidated Net Income / (Loss)
9.40 21 7.80 13 -1,367 0.90 -4.10 80 -9.20
Depreciation Expense
5.80 10 7.40 8.30 10 9.50 10 10 11
Amortization Expense
-1.40 -1.80 -1.80 -2.10 -2.00 -1.70 -1.50 -2.30 -0.90
Non-Cash Adjustments To Reconcile Net Income
73 -66 -54 -39 1,275 -234 -223 -251 -72
Changes in Operating Assets and Liabilities, net
190 278 132 237 158 287 198 95 392
Net Cash From Investing Activities
-68 -149 -90 -93 -56 65 -212 270 128
Net Cash From Continuing Investing Activities
-68 -149 -90 -93 -56 65 -212 270 128
Purchase of Property, Plant & Equipment
-11 -9.10 -6.60 -11 -13 -12 -6.70 -13 -16
Acquisitions
-1.30 -0.70 0.00 -1.80 -8.90 -0.80 -11 -0.10 -0.10
Purchase of Investments
-75 -187 -127 -136 -135 -111 -91 -83 -162
Sale and/or Maturity of Investments
19 49 45 55 100 189 -103 367 307
Other Investing Activities, net
- -0.90 -0.90 0.60 - -0.20 -0.40 -0.20 -2.00
Net Cash From Financing Activities
-0.40 114 -2.30 3.20 209 -3.70 -19 -78 -0.20
Net Cash From Continuing Financing Activities
-0.40 114 -2.30 3.20 209 -3.70 -19 -78 -0.20
Repayment of Debt
-49 50 0.00 - -5.00 -0.80 -0.80 -0.80 -0.70
Repurchase of Common Equity
- - 0.00 - - - -12 -70 -1.00
Payment of Dividends
-0.70 -0.80 -2.30 -1.80 -3.10 -2.90 -6.20 -7.10 -2.00
Cash Interest Paid
2.80 2.80 2.60 2.50 2.50 2.40 2.20 2.30 1.50
Cash Income Taxes Paid
14 13 3.30 23 18 15 5.10 27 17

Annual Balance Sheets for Accelerant

This table presents Accelerant's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
6,095 8,263
Total Current Assets
544 712
Short-Term Investments
544 712
Plant, Property, & Equipment, net
0.00 0.00
Total Noncurrent Assets
5,551 7,551
Long-Term Investments
64 94
Noncurrent Note & Lease Receivables
792 1,078
Goodwill
64 115
Other Noncurrent Operating Assets
4,548 6,264
Total Liabilities & Shareholders' Equity
6,095 8,263
Total Liabilities
5,668 7,537
Total Current Liabilities
400 594
Accounts Payable
400 594
Total Noncurrent Liabilities
5,268 6,943
Long-Term Debt
121 121
Other Noncurrent Operating Liabilities
5,147 6,822
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
427 726
Total Preferred & Common Equity
304 698
Total Common Equity
-78 698
Common Stock
125 2,232
Retained Earnings
-183 -1,537
Accumulated Other Comprehensive Income / (Loss)
-20 2.20
Noncontrolling Interest
18 29

Quarterly Balance Sheets for Accelerant

This table presents Accelerant's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
7,496 7,859 8,604 8,943 9,456
Total Current Assets
751 787 890 662 508
Short-Term Investments
751 787 890 662 508
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
6,745 7,073 7,714 8,281 8,948
Long-Term Investments
57 91 96 101 103
Noncurrent Note & Lease Receivables
938 922 1,183 1,157 1,177
Goodwill
120 117 112 111 111
Other Noncurrent Operating Assets
5,537 5,847 6,221 6,913 7,558
Total Liabilities & Shareholders' Equity
7,496 7,859 8,604 8,943 9,456
Total Liabilities
7,014 7,156 7,884 8,199 8,695
Total Current Liabilities
280 273 660 668 918
Accounts Payable
280 273 660 668 918
Total Noncurrent Liabilities
6,734 6,882 7,224 7,531 7,777
Long-Term Debt
127 122 121 120 120
Other Noncurrent Operating Liabilities
6,607 6,760 7,104 7,411 7,657
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
482 704 720 744 761
Total Preferred & Common Equity
346 676 693 717 732
Total Common Equity
-36 676 693 717 732
Common Stock
130 2,214 2,244 2,192 2,217
Retained Earnings
-168 -1,536 -1,542 -1,463 -1,476
Accumulated Other Comprehensive Income / (Loss)
1.70 -1.50 -8.80 -11 -9.10
Noncontrolling Interest
32 28 27 27 29

Annual Metrics And Ratios for Accelerant

This table displays calculated financial ratios and metrics derived from Accelerant's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 221,820,044.00
DEI Adjusted Shares Outstanding
0.00 0.00 221,820,044.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -6.42
Growth Metrics
- - -
Revenue Growth
0.00% 75.17% 51.49%
EBITDA Growth
0.00% 442.11% -2,074.46%
EBIT Growth
0.00% 233.64% -3,072.79%
NOPAT Growth
0.00% 374.65% -1,588.19%
Net Income Growth
0.00% 135.73% -5,974.24%
EPS Growth
0.00% 148.28% -5,450.00%
Operating Cash Flow Growth
0.00% 170.93% -43.35%
Free Cash Flow Firm Growth
0.00% 0.00% -908.37%
Invested Capital Growth
0.00% 0.00% 169.53%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
Gross Margin
100.00% 100.00% -51.13%
EBITDA Margin
-5.52% 10.79% -140.58%
Operating Margin
4.88% 12.94% -129.99%
EBIT Margin
-9.59% 7.32% -143.61%
Profit (Net Income) Margin
-18.63% 3.80% -147.35%
Tax Burden Percent
146.01% 71.56% 101.76%
Interest Burden Percent
133.03% 72.56% 100.83%
Effective Tax Rate
0.00% 28.44% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 5.36% -233.26%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -2,255.18%
Operating Return on Assets (OROA)
0.00% 0.72% -18.26%
Return on Assets (ROA)
0.00% 0.38% -18.74%
Return on Common Equity (ROCE)
0.00% -0.97% -125.43%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
12 56 -831
NOPAT Margin
3.42% 9.26% -90.99%
Net Nonoperating Expense Percent (NNEP)
0.00% -13.54% -87.84%
Return On Investment Capital (ROIC_SIMPLE)
- 10.18% -97.99%
Cost of Revenue to Revenue
0.00% 0.00% 151.13%
SG&A Expenses to Revenue
53.05% 41.37% 43.86%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
95.12% 87.06% 78.86%
Earnings before Interest and Taxes (EBIT)
-33 44 -1,311
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-19 65 -1,283
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.00 4.46
Price to Tangible Book Value (P/TBV)
0.00 0.00 5.34
Price to Revenue (P/Rev)
2.10 1.20 3.41
Price to Earnings (P/E)
0.00 26.61 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 3.76% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 59.43
Enterprise Value to Revenue (EV/Rev)
0.00 1.23 2.69
Enterprise Value to EBITDA (EV/EBITDA)
0.00 11.41 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 16.82 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 13.29 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.94 5.51
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 6.44 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.28 0.17
Long-Term Debt to Equity
0.00 0.28 0.17
Financial Leverage
0.00 -1.14 -1.02
Leverage Ratio
0.00 14.27 12.45
Compound Leverage Factor
0.00 10.36 12.55
Debt to Total Capital
0.00% 22.14% 14.31%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 22.14% 14.31%
Preferred Equity to Total Capital
0.00% 88.66% 0.00%
Noncontrolling Interests to Total Capital
0.00% 3.34% 3.39%
Common Equity to Total Capital
0.00% -14.13% 82.31%
Debt to EBITDA
0.00 1.87 -0.09
Net Debt to EBITDA
0.00 -7.48 0.53
Long-Term Debt to EBITDA
0.00 1.87 -0.09
Debt to NOPAT
0.00 2.17 -0.15
Net Debt to NOPAT
0.00 -8.71 0.82
Long-Term Debt to NOPAT
0.00 2.17 -0.15
Altman Z-Score
0.00 0.19 -0.41
Noncontrolling Interest Sharing Ratio
0.00% 118.15% 46.23%
Liquidity Ratios
- - -
Current Ratio
0.00 1.36 1.20
Quick Ratio
0.00 1.36 1.20
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 115 -931
Operating Cash Flow to CapEx
889.57% 2,284.01% 1,075.12%
Free Cash Flow to Firm to Interest Expense
0.00 9.52 -85.45
Operating Cash Flow to Interest Expense
26.61 64.93 40.83
Operating Cash Flow Less CapEx to Interest Expense
23.61 62.09 37.04
Efficiency Ratios
- - -
Asset Turnover
0.00 0.10 0.13
Accounts Receivable Turnover
0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 2.78
Days Sales Outstanding (DSO)
0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 131.43
Cash Conversion Cycle (CCC)
0.00 0.00 -131.43
Capital & Investment Metrics
- - -
Invested Capital
0.00 -59 41
Invested Capital Turnover
0.00 -20.29 -100.87
Increase / (Decrease) in Invested Capital
0.00 -59 101
Enterprise Value (EV)
0.00 742 2,454
Market Capitalization
724 724 3,111
Book Value per Share
$0.00 ($0.47) $3.15
Tangible Book Value per Share
$0.00 ($1.36) $2.63
Total Capital
0.00 548 848
Total Debt
0.00 121 121
Total Long-Term Debt
0.00 121 121
Net Debt
0.00 -486 -685
Capital Expenditures (CapEx)
33 34 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -400 -594
Debt-free Net Working Capital (DFNWC)
0.00 144 118
Net Working Capital (NWC)
0.00 144 118
Net Nonoperating Expense (NNE)
76 33 515
Net Nonoperating Obligations (NNO)
0.00 -486 -685
Total Depreciation and Amortization (D&A)
14 21 28
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -66.38% -65.02%
Debt-free Net Working Capital to Revenue
0.00% 23.95% 12.97%
Net Working Capital to Revenue
0.00% 23.95% 12.97%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($7.49)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 190.26M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($7.49)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 190.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 222.16M
Normalized Net Operating Profit after Tax (NOPAT)
12 56 -831
Normalized NOPAT Margin
3.42% 9.26% -90.99%
Pre Tax Income Margin
-12.76% 5.31% -144.80%
Debt Service Ratios
- - -
EBIT to Interest Expense
-3.03 3.64 -120.28
NOPAT to Interest Expense
1.08 4.61 -76.21
EBIT Less CapEx to Interest Expense
-6.02 0.80 -124.07
NOPAT Less CapEx to Interest Expense
-1.91 1.77 -80.01
Payout Ratios
- - -
Dividend Payout Ratio
-13.10% 15.28% -0.75%
Augmented Payout Ratio
-13.10% 15.28% -0.75%

Quarterly Metrics And Ratios for Accelerant

This table displays calculated financial ratios and metrics derived from Accelerant's official financial filings.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 0.00 0.00 0.00 219,986,563.00 222,160,004.00 218,201,340.00 217,188,552.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 219,986,563.00 222,160,004.00 218,201,340.00 217,188,552.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00 -6.54 -0.02 0.36 -0.06
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 68.41% 73.98% 53.54% 62.89% 4.19%
EBITDA Growth
0.00% 0.00% 0.00% 52.71% -15,405.68% -45.15% 215.81% 100.82%
EBIT Growth
0.00% 0.00% 0.00% 2,007.69% -30,893.18% -75.14% 262.10% 100.06%
NOPAT Growth
0.00% 0.00% 0.00% 484.09% -813.39% -397.50% 229.84% 102.00%
Net Income Growth
0.00% 0.00% 0.00% 242.39% -14,642.55% -152.56% 510.69% 99.33%
EPS Growth
0.00% 0.00% 0.00% 180.00% -17,575.00% -166.67% 800.00% 99.14%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -73.26% -123.31% -131.54% 334.37%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -186.52% 65.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 150.58% 617.08%
Revenue Q/Q Growth
0.00% 18.14% 0.00% 23.09% 22.04% 0.00% 30.59% -21.94%
EBITDA Q/Q Growth
0.00% -56.65% 0.00% 30.80% -2,725.54% 0.00% 653.08% -88.66%
EBIT Q/Q Growth
0.00% 438.46% 0.00% 37.02% -5,563.31% 0.00% 1,895.56% -99.11%
NOPAT Q/Q Growth
0.00% 2,351.58% 0.00% 84.65% -2,931.57% 0.00% 304.72% -81.87%
Net Income Q/Q Growth
0.00% 202.17% 0.00% 67.95% -10,535.11% 0.00% 2,051.22% -111.50%
EPS Q/Q Growth
0.00% 180.00% 0.00% 33.33% -17,575.00% 0.00% 1,900.00% -116.67%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -62.03% 136.93% 0.00% -134.57% -220.56% 567.93%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -473.75% 0.00% -306.83% -52.38%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 73.86% 0.00% 169.23% 167.26%
Profitability Metrics
- - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% -415.97% 100.00% 100.00% 100.00%
EBITDA Margin
15.60% 5.73% 13.31% 14.15% -503.70% 4.76% 27.43% 3.98%
Operating Margin
5.76% 11.58% 18.54% 23.82% -490.54% 8.82% 30.96% 9.40%
EBIT Margin
-1.00% 2.86% 10.17% 11.32% -506.69% 1.65% 25.16% 0.29%
Profit (Net Income) Margin
-7.07% 6.12% 4.38% 5.98% -511.22% -1.50% 22.42% -3.30%
Tax Burden Percent
213.95% 723.08% 50.32% 58.74% 100.70% -205.00% 91.53% 575.00%
Interest Burden Percent
330.77% 29.55% 85.64% 89.92% 100.19% 44.44% 97.33% -200.00%
Effective Tax Rate
0.00% -623.08% 49.68% 41.26% 0.00% 305.00% 8.47% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.11%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.53%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -63.47%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% -188.51% -210.44% 6.64%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.19% 3.51% 0.04%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -0.18% 3.13% -0.44%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% -181.36% -117.01% 6.38%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
5.25 129 17 31 -918 -49 101 18
NOPAT Margin
4.04% 83.74% 9.33% 14.00% -343.38% -18.08% 28.34% 6.58%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% -5.15% -118.75% 10.47% -3.19% -4.42%
Return On Investment Capital (ROIC_SIMPLE)
- - - 5.04% -111.20% -5.88% 11.71% 2.08%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 515.97% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
44.43% 43.79% 42.30% 40.67% 43.31% 45.30% 36.28% 50.07%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
94.24% 88.42% 81.46% 76.18% 74.57% 91.18% 69.04% 90.60%
Earnings before Interest and Taxes (EBIT)
-1.30 4.40 18 25 -1,355 4.50 90 0.80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
20 8.80 24 31 -1,347 13 98 11
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 4.54 4.28 3.59 5.85
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 6.61 6.20 4.24 6.90
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 2.94 2.25 3.70
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 70.71
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.41%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 19.43 14.19
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 2.11 1.71 3.30
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 29.22
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.77
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 24.13
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.68 0.00 6.41 42.75 13.05
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.26 0.17 0.17 0.16 0.16
Long-Term Debt to Equity
0.00 0.00 0.00 0.26 0.17 0.17 0.16 0.16
Financial Leverage
0.00 0.00 0.00 -1.41 -1.07 -1.20 -1.08 -0.85
Leverage Ratio
0.00 0.00 0.00 15.55 11.17 11.95 13.41 11.82
Compound Leverage Factor
0.00 0.00 0.00 13.98 11.19 5.31 13.05 -23.64
Debt to Total Capital
0.00% 0.00% 0.00% 20.81% 14.76% 14.36% 13.90% 13.57%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 20.81% 14.76% 14.36% 13.90% 13.57%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 79.85% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 5.19% 3.35% 3.25% 3.08% 3.30%
Common Equity to Total Capital
0.00% 0.00% 0.00% -5.85% 81.88% 82.39% 83.02% 83.12%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -0.09 -0.10 0.91
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.67 0.52 -3.76
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -0.09 -0.10 0.91
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -0.14 -0.15 0.75
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 1.03 0.81 -3.10
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -0.14 -0.15 0.75
Altman Z-Score
0.00 0.00 0.00 0.00 0.00 0.13 0.12 0.15
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 3.79% 44.40% 3.88%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 0.00 0.00 2.68 2.88 1.35 0.99 0.55
Quick Ratio
0.00 0.00 0.00 2.68 2.88 1.35 0.99 0.55
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 230 -866 96 -199 -303
Operating Cash Flow to CapEx
0.00% 2,467.86% 1,390.91% 2,032.71% 591.20% -319.40% -519.70% 2,018.87%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 91.99 -333.11 38.48 -82.90 -126.32
Operating Cash Flow to Interest Expense
0.00 89.16 35.31 87.00 28.42 -8.56 -28.58 133.75
Operating Cash Flow Less CapEx to Interest Expense
0.00 85.55 32.77 82.72 23.62 -11.24 -34.08 127.13
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.12 0.14 0.13
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 2.09 2.91 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 174.60 125.44 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 -174.60 -125.44 0.00
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 0.00 0.00 -199 -52 -146 101 269
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 -13.85 -23.27 10.65
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 -199 -52 -146 300 322
Enterprise Value (EV)
0.00 0.00 0.00 560 2,340 2,128 1,958 3,822
Market Capitalization
724 724 724 724 3,068 2,966 2,575 4,285
Book Value per Share
$0.00 $0.00 $0.00 ($0.21) $3.07 $3.12 $3.29 $3.37
Tangible Book Value per Share
$0.00 $0.00 $0.00 ($1.50) $2.11 $2.15 $2.78 $2.86
Total Capital
0.00 0.00 0.00 609 826 841 864 881
Total Debt
0.00 0.00 0.00 127 122 121 120 120
Total Long-Term Debt
0.00 0.00 0.00 127 122 121 120 120
Net Debt
0.00 0.00 0.00 -682 -756 -866 -643 -492
Capital Expenditures (CapEx)
0.00 11 6.60 11 13 6.70 13 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 -280 -273 -660 -668 -918
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 471 513 230 -6.10 -410
Net Working Capital (NWC)
0.00 0.00 0.00 471 513 230 -6.10 -410
Net Nonoperating Expense (NNE)
14 119 8.81 18 449 -45 21 28
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 -682 -756 -866 -643 -492
Total Depreciation and Amortization (D&A)
22 4.40 5.60 6.20 8.00 8.50 8.10 10
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% -65.46% -58.32% -79.35%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 22.83% -0.53% -35.42%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 22.83% -0.53% -35.42%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.05 ($6.99) ($0.02) $0.36 ($0.06)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 166.19M 206.06M 221.98M 218.41M 217.17M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.04 ($6.99) ($0.02) $0.36 ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 205.95M 206.06M 221.98M 219.69M 217.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 219.99M 221.82M 218.20M 217.19M 217.37M
Normalized Net Operating Profit after Tax (NOPAT)
5.25 12 17 31 -918 17 101 18
Normalized NOPAT Margin
4.04% 8.11% 9.33% 14.00% -343.38% 6.17% 28.34% 6.58%
Pre Tax Income Margin
-3.31% 0.85% 8.71% 10.18% -507.67% 0.73% 24.49% -0.57%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-0.43 1.42 6.96 9.92 -521.12 1.80 37.42 0.33
NOPAT to Interest Expense
1.75 41.52 6.39 12.27 -353.15 -19.76 42.14 7.64
EBIT Less CapEx to Interest Expense
0.00 -2.19 4.42 5.64 -525.92 -0.88 31.92 -6.29
NOPAT Less CapEx to Interest Expense
0.00 37.91 3.85 7.99 -357.96 -22.44 36.64 1.02
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -1.03% -1.50% 26.92%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -1.03% -1.50% 26.92%

Financials Breakdown Chart

Key Financial Trends

Accelerant Holdings (NYSE:ARX) showed a significant earnings recovery in the second quarter of 2026. Revenue increased to $356.9 million from $219.1 million in the year-ago quarter, while net income attributable to common shareholders rose to $78.7 million from $8.8 million. Basic and diluted earnings per share improved to $0.36 from $0.05.

Operating performance also strengthened. Operating income increased to $110.5 million from $52.2 million, and the operating margin expanded to approximately 31% from 24%. However, the comparison is affected by unusual results in third-quarter 2025, when a large cost-of-revenue charge contributed to a $1.37 billion net loss. Some prior-period figures have also been restated.

The main concern is cash-flow quality. Accelerant generated negative operating cash flow of $68.6 million in Q2 2026, compared with positive operating cash flow of $217.5 million in Q2 2025. The company’s $122.8 million increase in cash during the quarter was primarily supported by $366.5 million of investment sales and maturities, rather than operating cash generation.

  • Strong revenue growth: Q2 revenue rose approximately 63% year over year and 31% from Q1 2026, indicating continued expansion in the company’s operating base.
  • Material earnings improvement: Net income attributable to common shareholders increased to $78.7 million from $8.8 million in Q2 2025, reversing the weak profitability seen earlier in the period.
  • Improved operating profitability: Operating income more than doubled year over year to $110.5 million, with the operating margin reaching roughly 31%.
  • Lower debt balance: Long-term debt declined to $120.1 million from $126.7 million at June 30, 2025, while Q2 debt repayment remained modest at $0.8 million.
  • Shareholder returns continued: Accelerant repurchased approximately $70.4 million of common stock and paid $7.1 million in dividends during Q2 2026.
  • Balance sheet expanded: Total assets increased to $8.94 billion from $7.50 billion year over year, while total equity rose to $744.0 million from $482.2 million. Much of the asset base remains concentrated in noncurrent operating assets and receivables.
  • Investment portfolio remains important: Short-term investments totaled $662.2 million and long-term investments totaled $101.1 million at quarter-end. Investment sales provided a major source of liquidity in Q2, but future cash generation may vary with portfolio activity.
  • Operating cash flow deteriorated: Q2 operating cash flow was negative $68.6 million versus positive $217.5 million a year earlier. For the first half of 2026, operating cash flow was approximately negative $90.0 million, compared with roughly positive $309.3 million in the first half of 2025.
  • Liquidity coverage weakened: Reported current assets of $662.2 million were slightly below current liabilities of $668.3 million, producing a current ratio of approximately 0.99. This compares with a ratio of about 2.7 at June 30, 2025.
  • Equity quality and share count require monitoring: Retained earnings remained deeply negative at $1.46 billion, and weighted-average basic shares outstanding were 218.4 million in Q2 2026 versus 166.2 million in Q2 2025. The recent buyback reduced shares during the quarter, but the share count remains substantially higher than the year-ago level.

Overall, the statements point to improving revenue and profitability, but weaker operating cash flow and tighter reported liquidity temper the bullish earnings picture. Investors should watch whether future quarters convert the stronger accounting earnings into recurring operating cash flow without relying on investment sales.

11/16/26 12:31 PM ETAI Generated. May Contain Errors.

Accelerant Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Accelerant's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Accelerant's net income appears to be on a downward trend, with a most recent value of -$1.35 billion in 2025, falling from -$64.10 million in 2023. The previous period was $22.90 million in 2024. View Accelerant's forecast to see where analysts expect Accelerant to go next.

Accelerant's total operating income in 2025 was -$1.19 billion, based on the following breakdown:
  • Total Gross Profit: -$466.80 million
  • Total Operating Expenses: $719.90 million

Over the last 2 years, Accelerant's total revenue changed from $344 million in 2023 to $912.90 million in 2025, a change of 165.4%.

Accelerant had total debt of $121.30 million at the end of 2025, a 0.1% decrease from 2024, and none in 2023.

Over the last 2 years, Accelerant's book value per share changed from 0.00 in 2023 to 3.15 in 2025, a change of 314.5%.



Financial statements for NYSE:ARX last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners